New CSO for Cellbox Solutions

The Belgian native took over the cell and gene therapy division. She is considered an expert in the development of manufacturing processes and analytical methods for cell-based therapies and ex vivo gene therapies. Previously, she was Head of Science and Technology for Catalent Cell Therapy. The US company had acquired Masthercell Inc. in February 2020, where Deblandre was also CSO. Cellbox Solutions is specialised in the transport of living cells and biological structures at optimal conditions.